Ahmc Seton Medical Center LLC
Ahmc Seton Medical Center LLC was paid $5.21M by Medicaid between Dec 2020 and Nov 2024, across 155 billing codes. Its largest line is 0450, Emergency room services — 23% of everything it billed.
DALY CITY, CA 94015
Next to other General Acute Care Hospital providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 49 | $3K | |
| 2021 | 51,875 | $956K | |
| 2022 | 56,662 | $1.18M | |
| 2023 | 62,947 | $1.51M | |
| 2024incomplete | 51,129 | $1.57M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 23% | 15,678 | 14,380 | $1.18M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.5% | 2,058 | 1,981 | $392K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.1% | 1,322 | 1,306 | $265K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.5% | 1,780 | 1,740 | $233K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 3.5% | 1,010 | 689 | $180K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.3% | 2,207 | 2,157 | $170K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.0% | 1,841 | 1,577 | $154K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.8% | 2,909 | 2,904 | $147K |
| 93000 | 2.7% | 3,010 | 2,873 | $143K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.7% | 1,982 | 1,908 | $140K |
| 80053 | Comprehensive metabolic panel | 2.7% | 14,480 | 14,018 | $139K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.6% | 1,918 | 1,826 | $134K |
143 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 18,622 | $131K |
| 99284 | Emergency room visit (serious) | 2.1% | 1,257 | $111K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.9% | 7,572 | $99K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.9% | 6,165 | $97K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.7% | 899 | $89K |
| 99283 | Emergency room visit (moderate) | 1.2% | 1,110 | $64K |
| 80061 | Lipid panel | 1.2% | 9,363 | $63K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 4,263 | $60K |
| 0270 | 1.1% | 264 | $56K | |
| 99070 | 1.0% | 11,161 | $54K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,087 | $50K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 842 | $45K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,285 | $44K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 465 | $40K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 867 | $40K |
| 84484 | <1% | 3,344 | $40K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 483 | $34K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 332 | $33K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,123 | $32K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,595 | $32K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,274 | $32K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,828 | $32K |
| 83690 | <1% | 3,093 | $29K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 485 | $29K |
| 81005 | <1% | 11,885 | $28K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 908 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,829 | $27K |
| 99199 | Unlisted special service, procedure or report | <1% | 373 | $23K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,224 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,221 | $21K |
| 83880 | <1% | 1,323 | $21K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 786 | $20K |
| 84153 | <1% | 1,283 | $18K | |
| 97597 | <1% | 262 | $16K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 258 | $15K |
| 81025 | <1% | 1,764 | $15K | |
| 77080 | <1% | 1,647 | $14K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 62 | $14K |
| 83605 | <1% | 1,028 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,194 | $12K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 181 | $11K |
| 76770 | <1% | 305 | $11K | |
| 82043 | <1% | 4,628 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,236 | $11K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 193 | $10K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 346 | $10K |
| 84439 | <1% | 2,460 | $10K | |
| 82550 | <1% | 3,656 | $10K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 436 | $10K |
| 80076 | <1% | 1,252 | $10K | |
| 86480 | <1% | 265 | $10K | |
| 76830 | Ultrasound, transvaginal | <1% | 178 | $9K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,565 | $7K |
| 83970 | <1% | 500 | $7K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 866 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 316 | $6K |
| 73030 | <1% | 237 | $6K | |
| Z7502 | <1% | 165 | $6K | |
| 85379 | <1% | 436 | $6K | |
| 82077 | <1% | 304 | $6K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 12 | $5K |
| 73610 | <1% | 197 | $5K | |
| 87077 | <1% | 1,221 | $5K | |
| 71250 | <1% | 41 | $5K | |
| 73630 | <1% | 211 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 290 | $5K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 13 | $5K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 27 | $4K |
| 80069 | <1% | 1,294 | $4K | |
| 84550 | <1% | 2,154 | $4K | |
| 76536 | <1% | 92 | $4K | |
| 83735 | <1% | 666 | $4K | |
| 85610 | <1% | 1,083 | $4K | |
| 73564 | <1% | 123 | $4K | |
| 85730 | <1% | 620 | $4K | |
| 82607 | <1% | 1,514 | $4K | |
| 82962 | <1% | 813 | $3K | |
| 0271 | <1% | 26 | $3K | |
| 87040 | <1% | 132 | $3K | |
| 84466 | <1% | 884 | $3K | |
| 76642 | <1% | 39 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 44 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 585 | $2K |
| 0510 | <1% | 47 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 342 | $2K |
| 72110 | <1% | 54 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $2K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 134 | $2K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 83 | $2K |
| 83540 | <1% | 915 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 165 | $1K |
| 81001 | <1% | 324 | $1K | |
| 82728 | <1% | 503 | $1K | |
| 77065 | Tomosynthesis, mammo | <1% | 12 | $979.66 |
| 93971 | <1% | 12 | $952.16 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 124 | $756.36 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 140 | $688.41 |
| 86140 | <1% | 124 | $676.89 | |
| 84460 | <1% | 857 | $666.39 | |
| 84450 | <1% | 640 | $535.17 | |
| 85027 | <1% | 87 | $503.64 | |
| 0002A | <1% | 21 | $480.00 | |
| 82272 | <1% | 855 | $450.25 | |
| 73562 | <1% | 15 | $445.13 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,019 | $400.70 |
| 85652 | <1% | 274 | $379.86 | |
| 73130 | <1% | 12 | $363.36 | |
| 84100 | <1% | 128 | $357.31 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 80 | $333.97 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 63 | $330.89 |
| 73560 | <1% | 13 | $283.53 | |
| 84481 | <1% | 24 | $275.11 | |
| 82948 | <1% | 39 | $215.12 | |
| 84156 | <1% | 183 | $149.03 | |
| 82040 | <1% | 67 | $141.01 | |
| 85611 | <1% | 19 | $128.82 | |
| 87205 | <1% | 13 | $124.48 | |
| 82746 | <1% | 24 | $111.16 | |
| 86038 | <1% | 13 | $110.39 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 30 | $107.66 |
| 86900 | <1% | 24 | $83.57 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 24 | $76.22 |
| 85007 | <1% | 13 | $51.51 | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 18 | $48.57 |
| 86592 | <1% | 14 | $48.34 | |
| 84075 | <1% | 76 | $46.05 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 15 | $32.66 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 15 | $2.40 |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,086 | $1.60 |
| 0305 | 0% | 16 | $0.00 | |
| 0250 | 0% | 29 | $0.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 86 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 12 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 12 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 13 | $0.00 |
| 0258 | 0% | 13 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| 0301 | 0% | 16 | $0.00 | |
| C1753 | Catheter, intravascular ultrasound | 0% | 12 | $0.00 |
| 0300 | 0% | 16 | $0.00 | |
| 0730 | 0% | 15 | $0.00 | |
| 0272 | 0% | 15 | $0.00 | |
| 0320 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Ahmc Garfield Medical Center LP | Monterey Park, CA | $17.83M |
| Ahmc Whittier Hospital Medical | Whittier, CA | $15.12M |
| Ahmc Anaheim Regional Medical | Anaheim, CA | $14.21M |
| Ahmc Monterey Park Hospital LP | Monterey Park, CA | $10.85M |
| Ahmc Greater El Monte Community | South El Monte, CA | $9.17M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $6.96M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $6.90M |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $1.57M |
| Ahmc San Gabriel Valley Medical | San Gabriel, CA | $249K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $176K |
| Alhambra Hospital Medical Center, LP | Alhambra, CA | $34K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.